Reaching high-risk underserved individuals for cancer genetic counseling by video-teleconferencing

Journal of Community and Supportive Oncology

Volumn 14, Issue 4, 2016, Pages 162-168

  Mette, Lindsey A ^a   Pulido Saldívar, Anna María ^a   Poullard, Natalie E ^a   Torres, Ivette C ^a   Seth, Sarah G ^a   Pollock, Brad H ^a,b   Tomlinson, Gail E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; DOCTOR PATIENT RELATION; GENETIC COUNSELING; GENETIC RISK; HISPANIC; HUMAN; HUMAN EXPERIMENT; MEXICO; MODEL; QUESTIONNAIRE; SATISFACTION; TELECONFERENCE; TELEMEDICINE; TEXAS; VIDEORECORDING;

EID: 84973299457     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0247     Document Type: Article

References (30)

1. Center for Disease Control. Cancer among women. http://www.cdc.gov/cancer/dcpc/data/women.htm. Last updated August 20, 2015. Accessed March 28, 2016.
2. Kurian AW, Fish K, Shema SJ, Clarke CA. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010;12:R99.
3. American Cancer Society. Cancer Facts & Figures for Hispanics/Latinos 2012-2014. Atlanta: American Cancer Society, 2012. Accessed March 28, 2016.
4. Freedman RA, He Y, Winer EP, Keating NL. Racial/ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care? Health Serv Res. 2013;48:1669-1683.
5. Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9:222-231.
6. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specifc survival by race and ethnicity in the United States. JAMA. 2015;313:165-173.
7. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:2783-5788.
8. NCCN. Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Colorectal. Version 2.2015. http://www.nccn.org/professionals/physician-gls/pdf/genetics-colon.pdf. Last updated February 2015. Accessed March 28, 2016.
9. Almario CV, May FP, Ponce NA, Spiegel BM. Racial and ethnic disparities in colonoscopic examination of individuals with family history of colorectal cancer. Clin Gastroenterol Hepatol. 2015;13:1487-1495.
10. Decker KM, Singh H. Reducing inequities in colorectal cancer screening in North America. J Carcinog. 2014;13:12.
11. Ojinnaka CO, Choi Y, Kum HC, Bolin JN. Predictors of colorectal cancer screening: does rurality play a role? J Rural Health. 2015;31:254-268.
12. Texas Center for the Advancement of Literacy & Learning (TCALL). Percentage by country of illiterate adult Texans. http://www-tcall.tamu.edu/docs/09illitmap.html. Last update 2009. Accessed March 26, 2015.
13. Texas Quick Facts. United States Census Bureau website. www.census.gov. Updated July 1, 2014. Accessed March 26, 2016.
14. The South Texas Health Status Review: a health disparities roadmap. Ed: Ramirez AG, Tompson IM, Vela L. San Antonio, Texas: University of Texas Health Science Center at San Antonio; 2013.
15. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian. Version 2. http://www.nccn.org/professionals/physician-gls/pdf/genetics-screening.pdf. Last updated 2014. Accessed March 26, 2016.
16. US Preventative Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventative Services Task Force Recommendation statement. Ann Intern Med. 2014;160:271-281.
17. Kaufman B, Shapira-Frommer R, Schmutzler RK, et al. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol. 2014;33:244-250.
18. Isakof SJ, Mayer EL, He L, et al. TBCRC009: A Multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer. J Clin Oncol. 2015;33:1902-1909.
19. Gammon AD, Rothwell E, Simmon R, et al. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. J Genet Couns. 2011;20:625-638.
20. Glenn BA, Chawla N, Bastani R. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis. 2012;22:267-273.
21. Sussner KM, Jandorf L, Tompson HS, Valdimarsadottir HB. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psychooncology. 2013;22:1594-1504.
22. D'Agincourt-Canning L, McGillivray B, Panabaker K, et al. Evaluation of genetic counseling for hereditary cancer by videoconference in British Columbia. BC Med J 2008;50:554-559.
23. DeMarco TA, Peshkin BN, Mars BD, Tercyak KP. Patient satisfaction with cancer genetic counseling: a psychometric analysis of the genetic counseling satisfaction scale. Journal of Genet Couns. 2004;13:293-304
24. Sheldon H, Graham C, Pothecary N, Rasul F. Increasing response rates amongst black and minority ethnic and seldom heard groups. http://www.nhssurveys.org/survey/525. Published March 2007. Accessed March 29, 2016.
25. Ofstedal MB, Weir DR. Recruitment and retention of minority participants in the health and retirement study. Gerontologist. 2011;51:S8-S20.
26. Pieterse AH, Ausems MGEM, Spreeuwenberg P, van Dulmen S. Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for afected versus unafected women. Patient Educ Couns. 2011;85:425-431.
27. Rentala J, Platten U, Lindgren G, et al. Risk perception after genetic counseling in patients with increased risk of cancer. Hered Cancer Clin Pract. 2009;7:15.
28. Hilgert JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med. 2012;14:765-766.
29. McDonald E, Lamb A, Grillo B, Lucas L, Miesfeldt S. Acceptability of telemedicine and other caner genetic counseling models of service delivery in geographically remote settings. J Genet Couns. 2014;23:221-228.
30. Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155:97-107.